Rapid Dose Therapeutics Corp.
$400,000.00 CAD
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2019-2020
- Agreement period
- January 1, 2020 – December 31, 2021
- Reference
- nrc-cnrc:172-2019-2020-Q4-935556
Published purpose
Rapid Dose Therapeutics Corp. (RDT) is a publicly traded Canadian life science company (CSE: DOSE) that develops innovative, proprietary drug delivery technologies designed to improve health and wellness outcomes and improve quality of life. Our QuickStrip™ product line is an oral dissolvable film strip infused with a precise dose of active medicinal ingredient that is rapidly transferred through the oral mucosa under the tongue (sublingual delivery) or inside the mouth (buccal delivery), enabling high bioavailability and fast drug onset time. Our plan is to expand and scale up our product innovation program over 2019-2021 to support the commercial development and scaleup manufacturing of new QuickStrip™ oral thin film products.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.